Progenity Inc
NASDAQ:PROG
Progenity Inc
PP&E Net
Progenity Inc
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Progenity Inc
NASDAQ:PROG
|
PP&E Net
$4m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
PP&E Net
$5.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
10%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
PP&E Net
$2.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
|
CVS Health Corp
NYSE:CVS
|
PP&E Net
$30.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
13%
|
|
Cigna Corp
NYSE:CI
|
PP&E Net
$3.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
10%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
PP&E Net
$2.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
15%
|
See Also
What is Progenity Inc's PP&E Net?
PP&E Net
4m
USD
Based on the financial report for Dec 31, 2021, Progenity Inc's PP&E Net amounts to 4m USD.
What is Progenity Inc's PP&E Net growth rate?
PP&E Net CAGR 3Y
-36%
Over the last year, the PP&E Net growth was -77%. The average annual PP&E Net growth rates for Progenity Inc have been -36% over the past three years .